The NUT::NSD3 gene fusion has recently been described in a subset of thyroid carcinomas without classical features, so that there is a rationale for NUT immunohistochemistry and/or molecular testing in unusual cases. This evidence concerns the gene NUTM1 and thyroid gland carcinoma.